IP Library Assignment 024343/0751
Patent Assignment
Reel/Frame 024343/0751

Assignment of Assignor's Interest

Recorded: 2010-05-06 Pages: 10
Assignors
KNEISSEL, MICHAELA
Executed: 2008-12-04
HALLEUX, CHRISTINE
Executed: 2008-12-04
HU, SHOU-IH
Executed: 2009-01-29
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Property (1)
Compositions and Methods for Use for Antibodies Against Sclerostin
Patent: 7,879,322 →
Application: 12/249,050 →
Publication: US 2009/0130113
Related Assignments (8)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest May 6, 2010
From: MORPHOSYS AG
To: NOVARTIS AG
Reel/Frame 024343/0696 →
Assignment of Assignor's Interest May 6, 2010
From: DIEFENBACH-STREIBER, BEATE; PRASSLER, JOSEF
To: MORPHYSYS AG
Reel/Frame 024343/0665 →
Assignment of Assignor's Interest Sep 30, 2015
From: NOVARTIS PHARMA AG
To: MEREO BIOPHARMA 3 LIMITED
Reel/Frame 036696/0001 →
Assignment of Assignor's Interest Nov 3, 2015
From: NOVARTIS AG
To: NOVARTIS PHARMA AG
Reel/Frame 036952/0483 →
Security Interest Aug 10, 2017
From: MEREO BIOPHARMA 3 LIMITED
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 043523/0406 →
Change of Address May 23, 2018
From: MEREO BIOPHARMA 3 LIMITED
To: MEREO BIOPHARMA 3 LIMITED
Reel/Frame 047095/0330 →
Security Interest Nov 7, 2018
From: MEREO BIOPHARMA 3 LIMITED
To: KREOS CAPITAL V (UK) LIMITED
Reel/Frame 047446/0701 →
Release of Security Interest Dec 15, 2020
From: KREOS CAPITAL V (UK) LIMITED
To: MEREO BIOPHARMA 3 LIMITED
Reel/Frame 054658/0567 →